The drug Plerixafor is used to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM). Plerixafor is an inhibitor of the CXCR4 chemokine receptor and blocks binding of its cognate ligand, stromal cell-derived factor-1α (SDF-1α). SDF-1α and CXCR4 are recognized to play a role in the trafficking and homing of human hematopoietic stem cells (HSCs) to the marrow compartment. This medicine comes in 24 mg/1.2 mL (20 mg/mL) in single-dose vials to administer subcutaneously.
One can easily purchase Plerixafor 24 mg from generic medicine suppliers. For more details about Plerixafor, dial toll-free no. 1800-889-1064.